These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 20930489)

  • 1. [Clinical evaluation of drug information provided by the pharmacists in the intensive care unit].
    Imaura M; Kohata Y; Kobayashi K; Takahashi H; Yokoyama H; Akase T; Yamada Y
    Yakugaku Zasshi; 2010 Oct; 130(10):1361-8. PubMed ID: 20930489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of pharmacists' intervention on the antibiotic therapy for the methicillin-resistant Staphylococcus aureus (MRSA) infectious diseases in the intensive care unit].
    Imaura M; Kohata Y; Kobayashi K; Takahashi H; Yokoyama H; Akase T; Yamada Y
    Yakugaku Zasshi; 2011 Apr; 131(4):563-70. PubMed ID: 21467796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The economic impact of clinical pharmacists' unsolicited recommendations.
    Torok N; Brown G
    Hosp Pharm; 1992 Dec; 27(12):1052-3, 1056-8, 1060. PubMed ID: 10122507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of a clinical pharmacist on cost saving and cost avoidance in drug therapy in an intensive care unit.
    Chuang LC; Sutton JD; Henderson GT
    Hosp Pharm; 1994 Mar; 29(3):215-8, 221. PubMed ID: 10132696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development and evaluation of pharmaceutical services in the ICU/CCU by medical staffs].
    Miyazaki N; Sekine Y; Aoyama T; Yasuno N; Nakamura H; Yamada Y; Iga T
    Yakugaku Zasshi; 2004 May; 124(5):279-86. PubMed ID: 15118240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of a clinical pharmacist in a multidisciplinary intensive care unit.
    Montazeri M; Cook DJ
    Crit Care Med; 1994 Jun; 22(6):1044-8. PubMed ID: 8205814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [SETSUYAKU-BAG Campaign--investigation of outpatient's leftover drugs and promotion of proper reuse of leftover drugs to reduce medical expenses].
    Koyanagi K; Kubota T; Kobayashi D; Kihara T; Yoshida T; Miisho T; Saito Y; Uchigoshi H; Takaki J; Seo T; Shimazoe T
    Yakugaku Zasshi; 2013; 133(11):1215-21. PubMed ID: 23978848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of pharmacist recommendations on the cost of drug therapy in ICU patients at a Malaysian hospital.
    Zaidi ST; Hassan Y; Postma MJ; Ng SH
    Pharm World Sci; 2003 Dec; 25(6):299-302. PubMed ID: 14689820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of intensive care unit (ICU) drug use on hospital costs: a descriptive analysis, with recommendations for optimizing ICU pharmacotherapy.
    Weber RJ; Kane SL; Oriolo VA; Saul M; Skledar SJ; Dasta JF
    Crit Care Med; 2003 Jan; 31(1 Suppl):S17-24. PubMed ID: 12544972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Medical economics research on awareness of community pharmacists about raising pharmaceutical questions regarding prescriptions issued by physicians].
    Shikamura Y; Oyama A; Takahashi J; Akagi Y; Negishi K; Ijyuin K; Kamimura N; Aoyama T
    Yakugaku Zasshi; 2012; 132(6):753-61. PubMed ID: 22687734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expected net benefit of clinical pharmacy in intensive care medicine: a randomized interventional comparative trial with matched before-and-after groups.
    Claus BO; Robays H; Decruyenaere J; Annemans L
    J Eval Clin Pract; 2014 Dec; 20(6):1172-9. PubMed ID: 25470782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a pharmacist's and a nurse's interventions on cost of drug therapy in a medical intensive-care unit.
    Katona BG; Ayd PR; Walters JK; Caspi M; Finkelstein BW
    Am J Hosp Pharm; 1989 Jun; 46(6):1179-82. PubMed ID: 2750769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective, randomized trial to assess the cost impact of pharmacist-initiated interventions.
    McMullin ST; Hennenfent JA; Ritchie DJ; Huey WY; Lonergan TP; Schaiff RA; Tonn ME; Bailey TC
    Arch Intern Med; 1999 Oct; 159(19):2306-9. PubMed ID: 10547170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of physician education on knowledge of drug therapeutics and costs.
    Sumpton JE; Frewen TC; Rieder MJ
    Ann Pharmacother; 1992 May; 26(5):692-7. PubMed ID: 1591432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computer-guided academic detailing as part of a drug benefit program.
    Keys PW; Goetz CM; Keys PA; Sterchele JA; Snedden TM; Livengood BH
    Am J Health Syst Pharm; 1995 Oct; 52(20):2199-203; discussion 22034. PubMed ID: 8564590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relevance of drug-drug interaction in the ICU - perceptions of intensivists and pharmacists.
    Askari M; Eslami S; Louws M; Dongelmans D; Wierenga P; Kuiper R; Abu-Hanna A
    Stud Health Technol Inform; 2012; 180():716-20. PubMed ID: 22874285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of price information on physician prescribing patterns--a literature review.
    Zelnio RN; Gagnon JP
    Drug Intell Clin Pharm; 1979 Mar; 13(3):156-9. PubMed ID: 10297414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Drug Wastage in the Operating Rooms and Intensive Care Units of a Regional Health Service.
    Barbariol F; Deana C; Lucchese F; Cataldi G; Bassi F; Bove T; Vetrugno L; De Monte A
    Anesth Analg; 2021 May; 132(5):1450-1456. PubMed ID: 33667211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical pharmacists in palliative care: effects on drug therapy and drug expenses].
    Wolf C; Dörje F; Klein C; Ostgathe C
    Schmerz; 2019 Dec; 33(6):533-538. PubMed ID: 31463583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of a pediatric clinical pharmacist in the pediatric intensive care unit.
    Krupicka MI; Bratton SL; Sonnenthal K; Goldstein B
    Crit Care Med; 2002 Apr; 30(4):919-21. PubMed ID: 11940770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.